1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
26.54 -0.36 (-1.34%)
1.4M
XNAS Volume

XNAS 15 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Genmab (ADR) quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents